---
layout: page
title: MPEP Patent Appilcation Manual
image:
  feature: /wide/transmission-patent-gray-blueprint.jpg
---
   <head>
      <title>2405-</title>
      <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
</head>
      <li><a href="index.html">Manual of Patent Examining Procedure</a></li>
      <li><a href="mpep-2400.html"><span>Chapter 2400</span></a></li>
      <li><span>Section 2405</span></li>  </ul>
      <div id="yui-main">
         <div class="yui-b">
            <div class="yui-g">  <div xmlns:bf="http://www.uspto.gov/bf" id="article">
               <div>
                  <div xmlns="" class="Section" id="d0e240968">
                     <h1 class="page-title">2405
                        &nbsp;&nbsp;
                        Acceptable Depository  [R-08.2012]
                     </h1>
                     <div id="d0e240972" class="CFR">
                        <h4 class="CFR"><i>37&nbsp;C.F.R.&nbsp;1.803 &nbsp;
                              
                              
                              
                              Acceptable depository.</i></h4>
                        <ul style="list-style-type: none;">
                           <li id="d0e240977" class="nobull">(a) A deposit shall be
                              recognized for the purposes of these regulations if made in
                              <ul style="list-style-type: none;">
                                 <li id="" class="nobull">
                                    <p id=""></p>
                                 </li>
                                 <li id="d0e240981" class="nobull">(1) any International
                                    Depositary Authority (IDA) as established under the Budapest Treaty on
                                    the International Recognition of the Deposit of Microorganisms for the
                                    Purposes of Patent Procedure, or
                                 </li>
                                 <li id="d0e240985" class="nobull">(2) any other depository
                                    recognized to be suitable by the Office. Suitability will be determined
                                    by the Commissioner on the basis of the administrative and technical
                                    competence, and agreement of the depository to comply with the terms and
                                    conditions applicable to deposits for patent purposes. The Commissioner
                                    may seek the advice of impartial consultants on the suitability of a
                                    depository. The depository must:
                                    <ul style="list-style-type: none;">
                                       <li id="" class="nobull">
                                          <p id=""></p>
                                       </li>
                                       <li id="d0e240989" class="nobull">(i) Have a
                                          continuous existence;
                                       </li>
                                       <li id="d0e240993" class="nobull">(ii) Exist
                                          independent of the control of the depositor;
                                       </li>
                                       <li id="d0e240997" class="nobull">(iii) Possess the
                                          staff and facilities sufficient to examine the viability of a
                                          deposit and store the deposit in a manner which ensures that it is
                                          kept viable and uncontaminated;
                                       </li>
                                       <li id="d0e241001" class="nobull">(iv) Provide for
                                          sufficient safety measures to minimize the risk of losing
                                          biological material deposited with it;
                                       </li>
                                       <li id="d0e241005" class="nobull">(v) Be impartial
                                          and objective;
                                       </li>
                                       <li id="d0e241009" class="nobull">(vi) Furnish samples
                                          of the deposited material in an expeditious and proper manner;
                                          and
                                       </li>
                                       <li id="d0e241013" class="nobull">(vii) Promptly notify
                                          depositors of its inability to furnish samples, and the reasons
                                          why.
                                       </li>
                                    </ul>
                                 </li>
                              </ul>
                           </li>
                           <li id="d0e241017" class="nobull">(b) A depository seeking status
                              under paragraph (a)(2) of this section must direct a communication to the
                              Commissioner which shall:
                              <ul style="list-style-type: none;">
                                 <li id="" class="nobull">
                                    <p id=""></p>
                                 </li>
                                 <li id="d0e241021" class="nobull">(1) Indicate the name and
                                    address of the depository to which the communication
                                    relates;
                                 </li>
                                 <li id="d0e241025" class="nobull">(2) Contain detailed
                                    information as to the capacity of the depository to comply with the
                                    requirements of paragraph (a) (2) of this section, including information
                                    on its legal status, scientific standing, staff and
                                    facilities;
                                 </li>
                                 <li id="d0e241029" class="nobull">(3) Indicate that the
                                    depository intends to be available, for the purposes of deposit, to any
                                    depositor under these same conditions;
                                 </li>
                                 <li id="d0e241033" class="nobull">(4) Where the depository
                                    intends to accept for deposit only certain kinds of biological material,
                                    specify such kinds;
                                 </li>
                                 <li id="d0e241037" class="nobull">(5) Indicate the amount
                                    of any fees that the depository will, upon acquiring the status of
                                    suitable depository under paragraph (a) (2) of this section, charge for
                                    storage, viability statements and furnishings of samples of the
                                    deposit.
                                 </li>
                              </ul>
                           </li>
                           <li id="d0e241041" class="nobull">(c) A depository having status
                              under paragraph (a)(2) of this section limited to certain kinds of biological
                              material may extend such status to additional kinds of biological material by
                              directing a communication to the Commissioner in accordance with paragraph (b)
                              of this section. If a previous communication under paragraph (b) of this
                              section is of record, items in common with the previous communication may be
                              incorporated by reference.
                           </li>
                           <li id="d0e241045" class="nobull">(d) Once a depository is
                              recognized to be suitable by the Commissioner or has defaulted or discontinued
                              its performance under this section, notice thereof will be published in the
                              Official Gazette of the Patent and Trademark Office.
                           </li>
                        </ul>
                     </div>
                     <p id="d0e241049"><b><a href="mpep-9020-appx-r.html#d0e333237">37 CFR
                              1.803</a></b> indicates that a depository will be recognized as acceptable
                        for the purposes of these regulations if it is either an International Depositary Authority
                        (IDA) established under the Budapest Treaty, or if it is a depository recognized as
                        suitable by the Commissioner. After the effective date of these regulations, a deposit of
                        biological material which is made in a depository which is not recognized as acceptable
                        under this regulation will not be considered as satisfying the requirements of
                        <b><a href="mpep-9015-appx-l.html#d0e302824">35
                              U.S.C. 112</a></b>. See <i>Ex parte
                           Humphreys</i>, 24 USPQ2d 1255 (Bd. Pat. App. &amp; Int. 1992). On the other hand,
                        if a deposit is not required to satisfy the requirements of <b><a href="mpep-9015-appx-l.html#d0e302824">35 U.S.C.
                              112</a></b>, it is permissible to make reference to such a deposit even
                        though it may not be in a depository or made under the conditions which are acceptable
                        under these regulations. As new depositories are recognized as suitable by the
                        Commissioner, their identity will be announced in the <i>Official
                           Gazette</i>.
                     </p>
                     <p id="d0e241066">An organization may be recognized as
                        suitable by the Office if the procedure and conditions specified in <b><a href="mpep-9020-appx-r.html#d0e333237">37 CFR
                              1.803(a)(2)</a></b> and <b><a href="mpep-9020-appx-r.html#d0e333237">37 CFR 1.803(b)</a></b> are followed.
                        Generally, it is not the intention of the Office to recognize as suitable any organization
                        where the need for a suitable depository for patent purposes is being met by depositories
                        recognized as IDAs under the Budapest Treaty. Suitability will be judged by the
                        Commissioner, based on need and the information supplied by the organization seeking
                        status, and information obtained from other sources that may be consulted.
                     </p>
                     <p id="d0e241075">While there is a desire to provide
                        flexibility to a patent applicant in selecting an appropriate depository, these rules are
                        not intended to permit each patent applicant to become its own depository since both the
                        patent owner and the public have an interest in the continued availability and
                        accessibility of the deposit during the enforceable life of the patent, and the public has
                        a continuing interest in its availability when the patent is no longer enforceable. The
                        concept of a depository independent of the control of the depositor or an IDA as an
                        acceptable depository is based on the need and desire to ensure the safe and reliable
                        storage of a deposited biological material under circumstances that are substantially free
                        of the opportunity for intentional mishandling or negligent handling of the deposited
                        material. The use of an independent depository or internationally recognized depository
                        will tend to preserve the integrity of the deposit process against those that may
                        accidentally alter the deposited material, may wish to tamper with the deposited material
                        or may wish to resume control of its availability when the patent is no longer enforceable,
                        and will tend to preserve the interest of the public in the access to the biological
                        material once the term of the patent expires.
                     </p>
                     <p id="d0e241078">When a depository having status under
                        <b><a href="mpep-9020-appx-r.html#d0e333237">37
                              CFR 1.803(a)(2)</a></b> seeks to change the kinds of biological materials
                        that it will accept and maintain for the purposes of these rules, a communication
                        requesting such a change should be directed to the Commissioner containing the information
                        requested in <b><a href="mpep-9020-appx-r.html#d0e333237">37 CFR 1.803(b)</a></b>. When such a change is
                        requested, the requesting depository should provide a complete list of the kinds of
                        biological materials it will accept.
                     </p>
                     <p id="d0e241087"><b><a href="mpep-9020-appx-r.html#d0e333237">37 CFR
                              1.803(d)</a></b> indicates that once a depository is recognized as suitable
                        for the purposes of this rule, or has defaulted or discontinued its performance under this
                        section, notice thereof will be published in the <i>Official
                           Gazette</i> of the Patent and Trademark Office. A current list (as of January,
                        1998) of IDAs recognized under the Budapest Treaty, with addresses, is included below. The
                        mere fact that a deposit has been made in one of these depositories does not mean that the
                        terms of the deposit meet either the requirements of the Budapest Treaty or the deposit
                        regulations. Many of the depositories recognized under the Budapest Treaty have many
                        different arrangements under which biological material may be stored.
                     </p>
                     <p id="d0e241095">The World Intellectual Property
                        Organization (WIPO) publishes a Guide to the Deposit of Micro-organisms under the Budapest
                        Treaty (WIPO Publication No. 661 (E)) on the procedures and requirements concerning the
                        deposit of biological material, including procedures for obtaining a sample of deposited
                        material, in each of the international depository authorities.
                     </p>
                     <div class="Section">
                        <h2 class="section1" id="d0e241098">
                           &nbsp;&nbsp;CURRENT IDAs
                        </h2>
                        <p id="d0e241102">The following constitutes the list
                           of IDAs recognized under the Budapest Treaty. The list is current as of July, 2001. 
                        </p>
                        <p style="margin-left: 25pt;">Advanced Biotechnology Center (ABC) <br>Interlab Cell Line Collection<br>(Biotechnology Dept.)<br>Largo Rossana Benzi, 10<br>16132 Genova<br>Italy
                        </p>
                        <p style="margin-left: 25pt;">Agricultural Research Service <br>Culture Collection (NRRL) <br>1815 North University Street<br>Peoria, Illinois 61604<br>USA
                        </p>
                        <p style="margin-left: 25pt;">American Type Culture Collection (ATCC) <br>10801 University Blvd.<br>Manassas, Virginia 20110-2209<br>USA
                        </p>
                        <p style="margin-left: 25pt;">Australian Government Analytical <br>Laboratories (AGAL) <br>The New South Wales Regional
                           Laboratory<br>1, Suakin Street<br>Pymble, NSW 2073<br>Australia
                        </p>
                        <p style="margin-left: 25pt;">Belgian Coordinated Collections of <br>Microorganisms (BCCM)<br>Prime Minister’s Services<br>Federal Office for Scientific, Technical and <br>Cultural Affairs (OSTC)<br>Rue de la Science 8<br>B-1000 Brussells<br>Belgium
                        </p>
                        <p style="margin-left: 25pt;">Bureau of Microbiology at Health Canada
                           (BMHC)<br>Federal Laboratories for Health
                           Canada<br>Room H5190<br>1015 Arlington Street<br>Winnipeg, Manitoba<br>Canada R3E 3R2
                        </p>
                        <p style="margin-left: 25pt;">Centraalbureau voor Schimmelcultures (CBS) <br>Oosterstraat 1<br>Postbus 273<br>NL-3740 AG Baarn<br>Netherlands
                        </p>
                        <p style="margin-left: 25pt;">China Center for Type Culture Collection
                           (CCTCC)<br>Wuhan University<br>Wuhan 430072<br>China
                        </p>
                        <p style="margin-left: 25pt;">China General Microbiological Culture <br>Center (CGMCC)<br>China Committee for Culture Collection
                           of<br>Microorganisms<br>P.O. Box 2714<br>Beijing 100080<br>China
                        </p>
                        <p style="margin-left: 25pt;">Colección Española de Cultivos Tipo
                           (CECT)<br>Universidad de Valencia<br>Edificio de Investigación<br>Campus de Burjasot<br>46100 Burjasot (Valencia)<br>Spain
                        </p>
                        <p style="margin-left: 25pt;">Collection Nationale De Cultures <br>De Micro-organismes (CNCM) <br>Institut Pasteur<br>28, rue du Dr Roux<br>75724 Paris Cédex 15<br>France
                        </p>
                        <p style="margin-left: 25pt;">Collection of Industrial Yeasts
                           DBVPG<br>Applied Microbiology Section<br>Department of Plant Biology<br>Faculty of Agriculture<br>University of Perugia <br>Borgo 20 Giugno, 74<br>06122 Perugia<br>Italy
                        </p>
                        <p style="margin-left: 25pt;">Culture Collection of Algae and Protozoa (CCAP) <br>Institute of Freshwater Ecology<br>Windermere Laboratory<br>Ambleside, Cumbria LA22 0LP United Kingdom and Dunstaffnage Marine
                           Laboratory<br>P.O. Box 3<br>Oban, Argyll PA34 4AD <br>United Kingdom<br></p>
                        <p style="margin-left: 25pt;">Culture Collection of Yeasts (CCY)<br>Institute of Chemistry<br>Slovak Academy of Sciences<br>Dúbravská cesta 9<br>842 38 Bratislava,<br>Slovakia
                        </p>
                        <p style="margin-left: 25pt;">Czech Collection of Microorganisms
                           (CCM)<br>Masaryc University<br>ul. Tvrdého 14<br>602 00 Brno<br>Czech Republic
                        </p>
                        <p style="margin-left: 25pt;">DSMZ-Deutsche Sammlung von Mikroorganismen <br>und Zellkulturen GmbH (DSMZ) <br>Mascheroder Weg 1b<br>D-38124 Braunschweig<br>Germany
                        </p>
                        <p style="margin-left: 25pt;">European Collection of Cell Cultures
                           (ECACC)<br>Vaccine Research and Production
                           Laboratory<br>Public Health Laboratory Service<br>Centre for Applied Microbiology and
                           Research<br>Porton Down<br>Salisbury, Wiltshire SP4 0JG <br>United Kingdom
                        </p>
                        <p style="margin-left: 25pt;">Institute of Agriculture and Food Biotechnology
                           (IAFB)<br>Collection of Industrial
                           Microorganisms<br>Ul. Rakowiecka 36<br>02-532 Warsaw, Poland
                        </p>
                        <p style="margin-left: 25pt;">International Mycological Institute
                           (IMI)<br>Bakeham Lane<br>Englefield Green<br>Egham, Surrey TW20 9TY<br>United Kingdom
                        </p>
                        <p style="margin-left: 25pt;">International Patent Organism Depositary
                           (IPOD)<br>AIST Tsukuba Central 6<br>1-1, Higashi 1-chome<br>Tsukuba-shi, Ibaraki-Ken 305-8566<br>Japan
                        </p>
                        <p style="margin-left: 25pt;">Korean Cell Line Research Foundation
                           (KCLRF)<br>Cancer Research Institute<br>Seoul National University College of
                           Medicine<br>28 Yungon-dong, Chongno-gu<br>Seoul 110-799<br>Republic of Korea
                        </p>
                        <p style="margin-left: 25pt;"> Korean Collection for Type Cultures
                           (KCTC)<br>52, Oun-dong,<br>Yusong-Ku<br>Taejon 305-333<br>Republic of Korea
                        </p>
                        <p style="margin-left: 25pt;">Korean Culture Center of Microorganisms
                           (KCCM)<br>College of Engineering<br>Yonsei University<br>Sodaemun gu<br>Seoul 120-749<br>Republic of Korea
                        </p>
                        <p style="margin-left: 25pt;">Microbial Strain Collection of Latvia
                           (MSCL)<br>University of Latvia<br>Faculty of Biology<br>Blvd. Kronvalda 4<br>LV-1586 Riga<br>Latvia
                        </p>
                        <p style="margin-left: 25pt;">National Bank for Industrial Microorganisms and <br>Cell Cultures (NBIMCC) <br>125, Tsarigradskochausse Blvd.<br>Block 2<br>1113 Sofia<br>Bulgaria
                        </p>
                        <p style="margin-left: 25pt;">National Collection of Agricultural and Industrial <br>Microorganisms (NCAIM)<br>Department of Microbiology and
                           Biotechnology<br>University of Horticulture and the Food
                           Industry<br>Somlói ût 14-16 <br>H-1118 Budapest<br>Hungary
                        </p>
                        <p style="margin-left: 25pt;">National Collection of Type Cultures (NCTC) <br>Central Public Health Laboratory<br>61 Colindale Avenue<br>London, NW9 5HT<br>United Kingdom
                        </p>
                        <p style="margin-left: 25pt;">National Collection of Yeast Cultures (NCYC) <br>AFRC Institute of Food Research<br>Norwich Laboratory<br>Colney Lane<br>Norwich NR4 7UA<br>United Kingdom
                        </p>
                        <p style="margin-left: 25pt;">National Collections of Industrial, Food and <br>Marine Bacteria (NCIMB)<br>23 St. Machar Drive<br>Aberdeen AB2 1RY<br>Scotland, United Kingdom
                        </p>
                        <p style="margin-left: 25pt;">National Research Center of
                           Antibiotics<br>Nagatinskaya Street 3-a<br>Moscow 113105<br>Russian Federation
                        </p>
                        <p style="margin-left: 25pt;">Polish Collection of Microorganisms
                           (PCM)<br>Institute of Immunology and Experimental
                           Therapy<br>Polish Academy of Sciences<br>Ul. Weigla 12<br>53-114 Wroclaw<br>Poland
                        </p>
                        <p style="margin-left: 25pt;">Russian Collection of Microorganisms
                           (VKM)<br>Prospekt Naouki, 5<br>142292 Puschino (Moscow Region)<br>Russian Federation
                        </p>
                        <p style="margin-left: 25pt;">Russian National Collection of
                           Industrial<br>Microorganisms (VKPM)<br>GNII Genetika<br>Dorozhny proezd. 1<br>Moscow 113545<br>Russian Federation
                        </p>
                     </div>
                     <p align="right"><a href="#top">[top]</a></p>
                  </div>
               </div>
               <div>
                  <h1 class="page-title">&nbsp;</h1>
               </div>  </div>
            </div>
         </div>
      </div>
      <div class="yui-b">
         <div id="aside">  <div id="rdms-sub-nav-container" xmlns:bf="http://www.uspto.gov/bf">
            <ul id="sub-nav">
               <li xmlns=""><a href="s2401.html">2401-Introduction</a></li>
               <li xmlns=""><a href="s2402.html">2402-The Deposit Rules</a></li>
               <li xmlns=""><a href="s2403.html">2403-Deposit of Biological Material</a><ul>
                     <li><a href="s2403.html#d0e240728">2403.01-Material Capable of Self- Replication</a></li>
                     <li><a href="s2403.html#d0e240735">2403.02-Plant Material</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2404.html">2404-Need or Opportunity to Make a Deposit</a><ul>
                     <li><a href="s2404.html#d0e240816">2404.01-Biological Material That Is Known and Readily Available to the Public</a></li>
                     <li><a href="s2404.html#d0e240930">2404.02-Biological Material That Can Be Made or Isolated Without Undue Experimentation</a></li>
                     <li><a href="s2404.html#d0e240946">2404.03-Reference to a Deposit in the Specification</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2405.html">2405-Acceptable Depository</a></li>
               <li xmlns=""><a href="s2406.html">2406-Time of Making an Original Deposit</a><ul>
                     <li><a href="s2406.html#d0e241742">2406.01-Description in Application Specification</a></li>
                     <li><a href="s2406.html#d0e241769">2406.02-Deposit After Filing Date - Corroboration</a></li>
                     <li><a href="s2406.html#d0e241779">2406.03-Possible Loss of U.S. Filing Date in Other Countries</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2407.html">2407-Replacement or Supplement of Deposit</a><ul>
                     <li><a href="s2407.html#d0e241898">2407.01-In a Pending Application</a></li>
                     <li><a href="s2407.html#d0e241922">2407.02-After a Patent Has Issued</a></li>
                     <li><a href="s2407.html#d0e241949">2407.03-Failure to Replace</a></li>
                     <li><a href="s2407.html#d0e241964">2407.04-Treatment of Replacement</a></li>
                     <li><a href="s2407.html#d0e241982">2407.05-Exemption From Replacement</a></li>
                     <li><a href="s2407.html#d0e241992">2407.06-Replacement May Not Be Recognized</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2408.html">2408-Term of Deposit</a></li>
               <li xmlns=""><a href="s2409.html">2409-Viability of Deposit</a></li>
               <li xmlns=""><a href="s2410.html">2410-Furnishing of Samples</a><ul>
                     <li><a href="s2410.html#d0e242157">2410.01-Conditions of Deposit</a></li>
                     <li><a href="s2410.html#d0e242206">2410.02-Certification of Statement of Availability of Deposit</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2411.html">2411-Examination Procedures</a><ul>
                     <li><a href="s2411.html#d0e242312">2411.01-Rejections Based on Deposit Issue</a></li>
                     <li><a href="s2411.html#d0e242401">2411.02-Replies to Rejections Based on Deposit Issue</a></li>
                     <li><a href="s2411.html#d0e242424">2411.03-Application in Condition for Allowance Except for Deposit</a></li>
                     <li><a href="s2411.html#d0e242459">2411.04-After a Patent Has Been Granted</a></li>
                     <li><a href="s2411.html#d0e242505">2411.05-Content of Application with Respect to Deposited Material</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2412-2419.html">2412-2419-[Reserved]</a></li>
               <li xmlns=""><a href="s2420.html">2420-The Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures - the Sequence
                     Rules</a></li>
               <li xmlns=""><a href="s2421.html">2421-Overview of the Sequence Rules</a><ul>
                     <li><a href="s2421.html#d0e242552">2421.01-Applications Affected</a></li>
                     <li><a href="s2421.html#d0e242568">2421.02-Summary of the Requirements of the Sequence Rules</a></li>
                     <li><a href="s2421.html#d0e242594">2421.03-Notification of a Failure to Comply</a></li>
                     <li><a href="s2421.html#d0e242622">2421.04-Future Changes to the Sequence Rules</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2422.html">2422-Nucleotide and/or Amino Acid Sequence Disclosures in Patent Applications</a><ul>
                     <li><a href="s2422.html#d0e245121">2422.01-Definitions of Nucleotide and/or Amino Acids for Purpose of Sequence Rules</a></li>
                     <li><a href="s2422.html#d0e245175">2422.02-The Requirement for Exclusive Conformance; Sequences Presented in Drawing Figures</a></li>
                     <li><a href="s2422.html#d0e245191">2422.03-The Requirements for a Sequence Listing and Sequence Identifiers; Sequences Embedded in Application Text; Variants of a Presented
                           Sequence</a></li>
                     <li><a href="s2422.html#d0e245299">2422.04-The Requirement for a Computer Readable Copy of the Official Copy of the Sequence Listing</a></li>
                     <li><a href="s2422.html#d0e245330">2422.05-Reference to Previously Filed Identical Computer Readable Form; Continuing or Derivative Applications; Request for Transfer
                           of Computer Readable Form</a></li>
                     <li><a href="s2422.html#d0e245358">2422.06-Requirement for Statement Regarding Content of Official and Computer Readable Copies of Sequence Listing</a></li>
                     <li><a href="s2422.html#d0e245376">2422.07-Requirements for Compliance, Statements Regarding New Matter, and Sanctions for Failure to Comply</a></li>
                     <li><a href="s2422.html#d0e245454">2422.08-Presumptions Regarding Compliance</a></li>
                     <li><a href="s2422.html#d0e245470">2422.09-Box Sequence; Hand Delivery of Sequence Listings and Computer Readable Forms</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2423.html">2423-Symbols and Format To Be Used for Nucleotide and/or Amino Acid Sequence Data</a><ul>
                     <li><a href="s2423.html#d0e245579">2423.01-Format and Symbols To Be Used in Sequence Listings</a></li>
                     <li><a href="s2423.html#d0e245618">2423.02-Depiction of Coding Regions</a></li>
                     <li><a href="s2423.html#d0e245637">2423.03-Presentation and Enumeration of Sequences</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2424.html">2424-Requirements for Nucleotide and/or Amino Acid Sequences as Part of the Application Papers</a><ul>
                     <li><a href="s2424.html#d0e246252">2424.01-Informational Requirements for the Sequence Listing</a></li>
                     <li><a href="s2424.html#d0e246289">2424.02-Sequence Listing Numeric Identifiers</a></li>
                     <li><a href="s2424.html#d0e246838">2424.03-Additional Miscellaneous Requirements</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2425.html">2425-Form and Format for Nucleotide and/or Amino Acid Sequence Submissions in Computer Readable Form</a></li>
               <li xmlns=""><a href="s2426.html">2426-Amendments to or Replacement of Sequence Listing and Computer Readable Copy Thereof</a></li>
               <li xmlns=""><a href="s2427.html">2427-Form Paragraphs and Notice to Comply</a><ul>
                     <li><a href="s2427.html#d0e247062">2427.01-Form Paragraphs</a></li>
                     <li><a href="s2427.html#d0e247506">2427.02-Notice To Comply</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2428.html">2428-Sample Statements</a></li>
               <li xmlns=""><a href="s2429.html">2429-Helpful Hints for Compliance</a></li>
               <li xmlns=""><a href="s2430.html">2430-PatentIn Information; Utilities Programs; Training</a></li>
               <li xmlns=""><a href="s2431.html">2431-Sample Sequence Listing</a></li>
               <li xmlns=""><a href="s2432-2433.html">2432-2433-[Reserved]</a></li>
               <li xmlns=""><a href="s2434.html">2434-Examination of Patent Applications Claiming Large Numbers of Nucleotide Sequences</a></li>
               <li xmlns=""><a href="s2435.html">2435-Publishing of Patents and Patent Application Publications with Lengthy Sequence Listings</a></li>
            </ul>  </div>
         </div>
      </div>  </div>
      

  <div style="text-align:right"> Last Modified: 

     

    03/27/2014 10:10:34 

  </div>

</div>

</div>




<!-- End of footer2.html -->


   </body>
</html>